IL6 and central nervous system cancer: The mutual activation between glioma cells can be inhibited by a nanomedicine (i.e., Nano-DOX), which inhibits STAT3 activation in glioma cells, thereby abolishing IL-6-mediated STAT3 cross-activation in astrocytes and its promotion of glioma cells.